Life Sciences

Healthcare

Eurofins Discovery Introduces Innovative DiscoveryAI SAFIRE: A New AI-Driven Platform for Drug Discovery Trained Using Proprietary Datasets

Eurofins Discovery, part of the Eurofins network of laboratories and an industry-leading provider of products and services for drug discovery research, announces the launch...

Healthcare

Trinity Life Sciences Launches Brand Insights AI

New Chat-based AI Interface Allows Life Sciences Executives to Unlock the Collective Power of All Their Brand Research Trinity Life Sciences, a leader in global...

Healthcare

BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer

BullFrog AI Holdings, Inc., a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and...

Healthcare

ConcertAI’s TeraRecon Launches Three New Care Suites, Life Sciences Platform, and Strategic Partnerships at #ECR24

New Clinical AI care suites for Cardiology, Pulmonology, and Neurology; First-in-Class multi-modal predictive and Gen AI platform for research and clinical model development. ConcertAI's TeraRecon,...

Healthcare

Curia Appoints Steve Lavezoli as Vice President, Biologics

Curia, a leading contract research, development and manufacturing organization, announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26. Lavezoli...

Healthcare

Opentrons Announces Medical Robotics Expert Gregory Cole as Chief Innovation Officer to Accelerate AI-Driven Robo-Lab Partnerships and Innovations

Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics, announced the appointment of Gregory Cole, PhD as Chief Innovation...

Healthcare

Evaxion Announces Successful Initial Phases of Current Vaccine Collaboration with MSD

Evaxion Biotech A/S, a clinical research-focused biotechnology company specializing in the development of vaccines powered by AI-Immunology™, announces the success of the initial phases...

Healthcare

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI

Absci Corporation, a data-first generative AI drug creation company, announced the initiation of IND-enabling studies for ABS-101, a potential best-in-class anti-TL1A antibody designed using...

Healthcare

ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics

ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, announced the successful initial use of its Artificial...

Healthcare

Parse Biosciences Launches Evercode Whole Transcriptome Version 3, Boosting Usability and Performance

Transformative, instrument-free solution for single cell RNA sequencing updated with improved sensitivity, faster workflow Parse Biosciences, a leading provider of accessible and scalable single cell sequencing...